RheumNow Week in Review – 26 August 2016 Save

Dr. Jack Cush reviews news and journal reports from the past week on RheumNow.com.

1. Japanese study 345 RA pts shows sustained high CRP levels associated with increased risk of CKD (~20%) https://t.co/VWOxuHOCDl
2. Gout patients have a 17% increased risk of fracture (limbs & spine). Interestingly allopurinol use lowers risk http://buff.ly/2c1V2kI
3. SPIRIT-P1 Study published in Lancet; Ixekizumab (Taltz), IL-17 inhibitor, better than Placebo, but same as Humira at 24wks in psoriatic arthritis outcomes; but Taltz superior to Humira at Psoriasis outcomes. https://t.co/mVZ0sMSHdX
4. Hypotony (low intraocular pressure) is a sign of active, severe & usually symptomatic uveitis in Juvenile Arthritis https://t.co/qJOAWPcPpW
5. RCT of osteoporotic vertebral fractures (< 6 wks) showed vertebroplasty twice better than placebo in reducing pain https://t.co/aIeKdXTU1C
6. Risk factors for marginal ulcers in obesity gastric bypass surgery:Diabetes, Hx PUD, PPI & ASA use. But limited doses of. NSAIDs was not signif!cantly associated. PPI may be due to confounding by indication. https://t.co/9Ct4Xvmp2J
7. DESIR early SpA Cohort - Structural progression is low (~5%) in early SpA; Sacroiliitis risk factors were B27, smoking & MRI SI inflammation https://t.co/MWsxlbb6lt
8. Idiopathic Recurrent Pericarditis follows ~20% acute pericarditis; responds VERY well to IL-1 inhibition (anakinra) https://t.co/T28ggiTGyA
9. Since FDA approval 2011, Benlystas uptake has been slow, but had $265 million in worldwide sales in 2014. https://t.co/hqViTE0PEs
10. PsA have the same cancer & serious infx rates as non-PsA; but have more hematologic cancers & opportunistic infxns https://t.co/Mm9Ehpd19F
11. Prior Cancer Patients May Safely Receive TNF Inhibitors or Rituximab
12. Adalimumab Controls Non-Infectious Uveitis in VISUAL II Study
13. Risk of Sepsis or Death Lower with Biologics in Rheumatoid Arthritis.
14. EULAR 2016: Name that Country